109 related articles for article (PubMed ID: 24090732)
1. Use of the pentagastrin dog model to explore the food effects on formulations in early drug development.
Zane P; Guo Z; MacGerorge D; Vicat P; Ollier C
Eur J Pharm Sci; 2014 Jun; 57():207-13. PubMed ID: 24090732
[TBL] [Abstract][Full Text] [Related]
2. Development of a canine model to enable the preclinical assessment of pH-dependent absorption of test compounds.
Fancher RM; Zhang H; Sleczka B; Derbin G; Rockar R; Marathe P
J Pharm Sci; 2011 Jul; 100(7):2979-88. PubMed ID: 21254068
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Acid Tolerance of Drugs Using Rats and Dogs Controlled for Gastric Acid Secretion.
Kosugi Y; Yamamoto S; Sano N; Furuta A; Igari T; Fujioka Y; Amano N
J Pharm Sci; 2015 Sep; 104(9):2887-93. PubMed ID: 25720462
[TBL] [Abstract][Full Text] [Related]
4. The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human.
Wu Y; Loper A; Landis E; Hettrick L; Novak L; Lynn K; Chen C; Thompson K; Higgins R; Batra U; Shelukar S; Kwei G; Storey D
Int J Pharm; 2004 Nov; 285(1-2):135-46. PubMed ID: 15488686
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a preclinical food effect model.
Lentz KA; Quitko M; Morgan DG; Grace JE; Gleason C; Marathe PH
J Pharm Sci; 2007 Feb; 96(2):459-72. PubMed ID: 17075867
[TBL] [Abstract][Full Text] [Related]
6. Modification of gastric pH in the fasted dog.
Polentarutti B; Albery T; Dressman J; Abrahamsson B
J Pharm Pharmacol; 2010 Apr; 62(4):462-9. PubMed ID: 20604835
[TBL] [Abstract][Full Text] [Related]
7. Influence of central and peripheral administration of pancreatic polypeptide on gastric mucosa growth.
Dembiński A; Warzecha Z; Ceranowicz P; Pawlik M; Dembiński M; Kabat K; Konturek SJ; Kownacki P; Hładki W; Pawlik WW
J Physiol Pharmacol; 2004 Mar; 55(1 Pt 2):223-37. PubMed ID: 15082880
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the GI transit conditions in Beagle dogs with a telemetric motility capsule.
Koziolek M; Grimm M; Bollmann T; Schäfer KJ; Blattner SM; Lotz R; Boeck G; Weitschies W
Eur J Pharm Biopharm; 2019 Mar; 136():221-230. PubMed ID: 30703546
[TBL] [Abstract][Full Text] [Related]
9. Fundic inhibition of acid secretion and gastrin release in the dog.
Soon-Shiong P; Debas HT
Gastroenterology; 1980 Nov; 79(5 Pt 1):867-72. PubMed ID: 7419010
[TBL] [Abstract][Full Text] [Related]
10. Effects of Helicobacter pylori on gastritis, pentagastrin-stimulated gastric acid secretion, and meal-stimulated plasma gastrin release in the absence of peptic ulcer disease.
Hurlimann S; Dür S; Schwab P; Varga L; Mazzucchelli L; Brand R; Halter F
Am J Gastroenterol; 1998 Aug; 93(8):1277-85. PubMed ID: 9707051
[TBL] [Abstract][Full Text] [Related]
11. Food Effect in Humans: Predicting the Risk Through In Vitro Dissolution and In Vivo Pharmacokinetic Models.
Mathias N; Xu Y; Vig B; Kestur U; Saari A; Crison J; Desai D; Vanarase A; Hussain M
AAPS J; 2015 Jul; 17(4):988-98. PubMed ID: 25933598
[TBL] [Abstract][Full Text] [Related]
12. pH-dependent dissolution in vitro and absorption in vivo of weakly basic drugs: development of a canine model.
Zhou R; Moench P; Heran C; Lu X; Mathias N; Faria TN; Wall DA; Hussain MA; Smith RL; Sun D
Pharm Res; 2005 Feb; 22(2):188-92. PubMed ID: 15783065
[TBL] [Abstract][Full Text] [Related]
13. Fed and fasted state gastro-intestinal in vitro lipolysis: In vitro in vivo relations of a conventional tablet, a SNEDDS and a solidified SNEDDS.
Christophersen PC; Christiansen ML; Holm R; Kristensen J; Jacobsen J; Abrahamsson B; Müllertz A
Eur J Pharm Sci; 2014 Jun; 57():232-9. PubMed ID: 24056027
[TBL] [Abstract][Full Text] [Related]
14. Fed and fasted gastric pH and gastric residence time in conscious beagle dogs.
Sagawa K; Li F; Liese R; Sutton SC
J Pharm Sci; 2009 Jul; 98(7):2494-500. PubMed ID: 19177514
[TBL] [Abstract][Full Text] [Related]
15. Secretin inhibits canine gastric acid secretion in response to pentagastrin by modulating gastric histamine release.
Gerber JG; Payne NA
J Pharmacol Exp Ther; 1996 Nov; 279(2):718-23. PubMed ID: 8930176
[TBL] [Abstract][Full Text] [Related]
16. Histamine release in vivo by pentagastrin from the canine stomach.
Gerber JG; Barnes JS
J Pharmacol Exp Ther; 1987 Dec; 243(3):887-92. PubMed ID: 2447270
[TBL] [Abstract][Full Text] [Related]
17. Development of gastric acid secretion in pigs from birth to thirty six days of age: the response to pentagastrin.
Xu RJ; Cranwell PD
J Dev Physiol; 1990 Jun; 13(6):315-26. PubMed ID: 2084190
[TBL] [Abstract][Full Text] [Related]
18. Interests of the 'artificial stomach' techniques to study antacid formulations: comparison with in vivo evaluation.
Vatier J; Célice-Pingaud C; Farinotti R
Fundam Clin Pharmacol; 1998; 12(6):573-83. PubMed ID: 9818289
[TBL] [Abstract][Full Text] [Related]
19. In vivo methods for drug absorption - comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation/API/excipient characterization including food effects.
Sjögren E; Abrahamsson B; Augustijns P; Becker D; Bolger MB; Brewster M; Brouwers J; Flanagan T; Harwood M; Heinen C; Holm R; Juretschke HP; Kubbinga M; Lindahl A; Lukacova V; Münster U; Neuhoff S; Nguyen MA; Peer Av; Reppas C; Hodjegan AR; Tannergren C; Weitschies W; Wilson C; Zane P; Lennernäs H; Langguth P
Eur J Pharm Sci; 2014 Jun; 57():99-151. PubMed ID: 24637348
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and absorption of the anticancer agents dasatinib and GDC-0941 under various gastric conditions in dogs--reversing the effect of elevated gastric pH with betaine HCl.
Pang J; Dalziel G; Dean B; Ware JA; Salphati L
Mol Pharm; 2013 Nov; 10(11):4024-31. PubMed ID: 23980865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
